Other Liabilities, Noncurrent of BIO-RAD LABORATORIES, INC. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
BIO-RAD LABORATORIES, INC. quarterly Other Liabilities, Noncurrent in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Other Liabilities, Noncurrent for the quarter ending 31 Dec 2025 was $199,100,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $199,100,000 +$21,900,000 +12% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $207,500,000 +$9,869,000 +5% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $209,600,000 +$16,063,000 +8.3% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $173,100,000 -$19,318,000 -10% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $177,200,000 -$17,800,000 -9.1% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $197,631,000 +$11,510,000 +6.2% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $193,537,000 -$8,757,000 -4.3% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $192,418,000 -$6,831,000 -3.4% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $195,000,000 -$912,000 -0.47% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $186,121,000 -$18,970,000 -9.2% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $202,294,000 +$25,479,000 +14% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $199,249,000 +$19,160,000 +11% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $195,912,000 +$13,721,000 +7.5% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $205,091,000 -$9,200,000 -4.3% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $176,815,000 -$41,927,000 -19% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $180,089,000 -$48,781,000 -21% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $182,191,000 -$14,780,000 -7.5% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $214,291,000 +$32,206,000 +18% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $218,742,000 +$43,721,000 +25% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $228,870,000 +$55,613,000 +32% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $196,971,000 +$36,048,000 +22% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $182,085,000 +$38,610,000 +27% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $175,021,000 +$29,674,000 +20% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $173,257,000 +$29,573,000 +21% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $160,923,000 +$13,157,000 +8.9% 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $143,475,000 -$28,796,000 -17% 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $145,347,000 -$33,827,000 -19% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $143,684,000 -$47,304,000 -25% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $147,766,000 -$35,510,000 -19% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $172,271,000 +$24,492,000 +17% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $179,174,000 +$31,051,000 +21% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $190,988,000 -$212,522,000 -53% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $183,276,000 +$42,739,000 +30% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $147,779,000 +$7,244,000 +5.2% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $148,123,000 -$267,489,000 -64% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $403,510,000 +$29,414,000 +7.9% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $140,537,000 +$30,031,000 +27% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 $140,535,000 +$29,475,000 +27% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $415,612,000 +$300,679,000 +262% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 $374,096,000 +$98,956,000 +36% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 $110,506,000 -$8,229,000 -6.9% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $111,060,000 -$158,712,000 -59% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $114,933,000 -$187,019,000 -62% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $275,140,000 -$16,773,000 -5.7% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 $118,735,000 +$1,864,000 +1.6% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $269,772,000 +$12,030,000 +4.7% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $301,952,000 +$54,117,000 +22% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 $291,913,000 +$45,653,000 +19% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $116,871,000 +$8,776,000 +8.1% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $257,742,000 +$56,107,000 +28% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $247,835,000 +$80,670,000 +48% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $246,260,000 +$74,411,000 +43% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $108,095,000 +$32,009,000 +42% 31 Dec 2012 10-K 18 Mar 2014 2013 FY
Q3 2012 $201,635,000 +$72,409,000 +56% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $167,165,000 +$23,010,000 +16% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $171,849,000 +$35,369,000 +26% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $76,086,000 +$11,306,000 +17% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 $129,226,000 +$19,422,000 +18% 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 $144,155,000 +$43,597,000 +43% 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 $136,480,000 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q4 2010 $64,780,000 31 Dec 2010 10-K 29 Feb 2012 2011 FY
Q3 2010 $109,804,000 30 Sep 2010 10-Q 09 Nov 2010 2010 Q3
Q2 2010 $100,558,000 30 Jun 2010 10-Q 06 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.